Pneumothorax Incidence in Patients With Chronic Lung Comorbidities Receiving Continuous Positive Airway Pressure and Noninvasive Ventilation: A Retrospective Observational Study in a District General Hospital

Introduction Continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) are widely used in acute and chronic respiratory failure. CPAP is commonly used for obstructive sleep apnea-hypopnea syndrome, while NIV has an established role in acute hypercapnic respiratory failure and selected patients with chronic ventilatory failure. Many patients have underlying chronic lung disease, potentially increasing the risk of barotrauma and pneumothorax. Real-world data on pneumothorax incidence among these patients remain poorly described. We aimed to describe the occurrence of documented pneumothorax and explore its association with chronic respiratory comorbidities. Materials and methods We conducted a retrospective observational study of 306 adults manually selected at random from patients receiving CPAP or NIV between May 2023 and May 2025 across outpatient, inpatient, and emergency settings at Blackpool Victoria Hospital, Blackpool, United Kingdom. Clinical records and available chest imaging were reviewed for documented pneumothorax and respiratory comorbidities (chronic obstructive pulmonary disease (COPD), bronchiectasis, and interstitial lung disease (ILD)). Follow-up imaging was not systematic. Smoking history was recorded separately. Descriptive statistics, exact 95% confidence intervals (CIs), and two-sided Fisher's exact tests were used. The study received institutional clinical audit approval, and all analysed data were de-identified. Results A total of 306 patients were included. Pneumothorax was documented in two patients following CPAP/NIV initiation, representing 0.7% (2/306; 95% exact binomial CI: 0.1%-2.3%). Overall, 203 patients (66.3%) had at least one respiratory comorbidity, including COPD in 60 (19.6%), bronchiectasis in 17 (5.6%), ILD in 16 (5.2%), and other comorbidities in 118 (38.6%). Smoking history was recorded separately in 67 patients (21.9%). Both patients with pneumothorax had underlying chronic respiratory disease: one had COPD, and the other had ILD. No statistically significant association was observed for the presence of any respiratory comorbidity (p = 0.552), COPD (p = 0.354), or ILD (p = 0.102). Discussion Documented pneumothorax was uncommon in this heterogeneous CPAP/NIV cohort despite the high prevalence of respiratory comorbidities. However, non-systematic follow-up imaging may have led to underestimation of its occurrence. With only two events, associations with individual comorbidities could not be reliably assessed. These findings provide descriptive real-world evidence but do not establish the safety of CPAP/NIV or exclude increased pneumothorax risk in patients with chronic lung disease. Conclusions Documented pneumothorax was uncommon among patients receiving CPAP/NIV, despite a high prevalence of respiratory comorbidities. However, the small number of events and non-systematic follow-up imaging limit conclusions regarding its true occurrence and associated risk factors. Further studies with systematic monitoring and larger populations are needed to better assess pneumothorax risk in these patients.

Authors

Publication Details

Journal
Cureus
Published
2026-11-19
DOI
https://doi.org/10.7759/cureus.119934
Primary Topic
Pneumothorax, Barotrauma, Emphysema
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pneumothorax Incidence in Patients With Chronic Lung Comorbidities Receiving Continuous Positive Airway Pressure and Noninvasive Ventilation: A Retrospective Observational Study in a District General Hospital

Amr Bazaraa, A. Shams, Mohsen Mosallam, Alaa Elgohary et al.
Cureus
Pneumothorax, Barotrauma, Emphysema
article

Pneumothorax Incidence in Patients With Chronic Lung Comorbidities Receiving Continuous Positive Airway Pressure and Noninvasive Ventilation: A Retrospective Observational Study in a District General Hospital

Amr Bazaraa, A. Shams, Mohsen Mosallam, Alaa Elgohary, Rana Breika, Hashim Hameed, Ahmed Khaled
article en

Abstract

Introduction Continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) are widely used in acute and chronic respiratory failure. CPAP is commonly used for obstructive sleep apnea-hypopnea syndrome, while NIV has an established role in acute hypercapnic respiratory failure and selected patients with chronic ventilatory failure. Many patients have underlying chronic lung disease, potentially increasing the risk of barotrauma and pneumothorax. Real-world data on pneumothorax incidence among these patients remain poorly described. We aimed to describe the occurrence of documented pneumothorax and explore its association with chronic respiratory comorbidities. Materials and methods We conducted a retrospective observational study of 306 adults manually selected at random from patients receiving CPAP or NIV between May 2023 and May 2025 across outpatient, inpatient, and emergency settings at Blackpool Victoria Hospital, Blackpool, United Kingdom. Clinical records and available chest imaging were reviewed for documented pneumothorax and respiratory comorbidities (chronic obstructive pulmonary disease (COPD), bronchiectasis, and interstitial lung disease (ILD)). Follow-up imaging was not systematic. Smoking history was recorded separately. Descriptive statistics, exact 95% confidence intervals (CIs), and two-sided Fisher's exact tests were used. The study received institutional clinical audit approval, and all analysed data were de-identified. Results A total of 306 patients were included. Pneumothorax was documented in two patients following CPAP/NIV initiation, representing 0.7% (2/306; 95% exact binomial CI: 0.1%-2.3%). Overall, 203 patients (66.3%) had at least one respiratory comorbidity, including COPD in 60 (19.6%), bronchiectasis in 17 (5.6%), ILD in 16 (5.2%), and other comorbidities in 118 (38.6%). Smoking history was recorded separately in 67 patients (21.9%). Both patients with pneumothorax had underlying chronic respiratory disease: one had COPD, and the other had ILD. No statistically significant association was observed for the presence of any respiratory comorbidity (p = 0.552), COPD (p = 0.354), or ILD (p = 0.102). Discussion Documented pneumothorax was uncommon in this heterogeneous CPAP/NIV cohort despite the high prevalence of respiratory comorbidities. However, non-systematic follow-up imaging may have led to underestimation of its occurrence. With only two events, associations with individual comorbidities could not be reliably assessed. These findings provide descriptive real-world evidence but do not establish the safety of CPAP/NIV or exclude increased pneumothorax risk in patients with chronic lung disease. Conclusions Documented pneumothorax was uncommon among patients receiving CPAP/NIV, despite a high prevalence of respiratory comorbidities. However, the small number of events and non-systematic follow-up imaging limit conclusions regarding its true occurrence and associated risk factors. Further studies with systematic monitoring and larger populations are needed to better assess pneumothorax risk in these patients.

Cureus
Pneumothorax, Barotrauma, Emphysema
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon